BioCryst Pharmaceuticals Inc (BCRX)

7.62 +0.04 (+0.53%) USD  |  NASDAQ  |  Sep 27, 16:00
7.62 0.00 (0.00%) Pre-Market: 20:00
More

BioCryst Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2022. Upgrade now.
Date Value
June 30, 2024 --
March 31, 2024 --
December 31, 2023 --
September 30, 2023 --
June 30, 2023 --
Date Value
March 31, 2023 --
December 31, 2022 --
September 30, 2022 --
June 30, 2022 --

Quarterly Actual Revenue Range, Past 5 Years

Upgrade
Minimum
Jun 2022
Upgrade
Maximum
Jun 2024
Upgrade
Average
Upgrade
Median
Jun 2023

Quarterly Actual Revenue Benchmarks

Novavax Inc Upgrade
AIM ImmunoTech Inc Upgrade
Perspective Therapeutics Inc Upgrade
Protalix BioTherapeutics Inc Upgrade
Armata Pharmaceuticals Inc Upgrade